Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Apr/27/2021 40 46
Chloroquine phosphate Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/27/2021 25 9
Dexamethasone Emergency use authorization Used to treat other disease Other treatment Apr/23/2021 13 1
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Apr/23/2021 82 20
Ambroxol Potential treatment - pre-clinical evidence Natural product Other treatment Apr/22/2021 2 0
Favipiravir Approved for COVID-19 treatment (China, India, Russia) Used to treat other disease Antiviral Apr/16/2021 24 7
Methylprednisolone Potential treatment - clinical evidence Used to treat other disease Other treatment Apr/10/2021 35 4
Epigallocatechin Gallate Potential treatment - pre-clinical evidence Natural product Antiviral Apr/08/2021 11 0
Nafamostat mesylate Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/20/2021 12 0
Bictegravir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/18/2021 4 0